Prescribing Isotretinoin: FDA Approves iPLEDGE Modifications



Modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy aim to reduce challenges for patients, prescribers and pharmacies.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/fda-approves-ipledge-modifications-addressing-isotretinoin-2026a100049o?src=rss

Author :

Publish date : 2026-02-10 20:17:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version